CN105624174A - Gene for promoting pyruvic acid secretion and extraction method and application thereof - Google Patents
Gene for promoting pyruvic acid secretion and extraction method and application thereof Download PDFInfo
- Publication number
- CN105624174A CN105624174A CN201610096612.4A CN201610096612A CN105624174A CN 105624174 A CN105624174 A CN 105624174A CN 201610096612 A CN201610096612 A CN 201610096612A CN 105624174 A CN105624174 A CN 105624174A
- Authority
- CN
- China
- Prior art keywords
- gene
- psac
- phosphorus
- cdna
- escherichia coli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 33
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 title abstract description 8
- 229940107700 pyruvic acid Drugs 0.000 title abstract description 4
- 238000000605 extraction Methods 0.000 title abstract description 3
- 230000001737 promoting effect Effects 0.000 title description 2
- 230000009858 acid secretion Effects 0.000 title 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 34
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 34
- 239000011574 phosphorus Substances 0.000 claims abstract description 34
- 241000588724 Escherichia coli Species 0.000 claims abstract description 20
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 238000010367 cloning Methods 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 108010020248 psaB subunit photosystem I Proteins 0.000 claims description 22
- 239000002299 complementary DNA Substances 0.000 claims description 21
- 241000228245 Aspergillus niger Species 0.000 claims description 11
- 241000894006 Bacteria Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 108020004999 messenger RNA Proteins 0.000 claims description 5
- 108700026244 Open Reading Frames Proteins 0.000 claims description 4
- 238000012163 sequencing technique Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 claims description 2
- 230000005611 electricity Effects 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 238000001400 expression cloning Methods 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 230000007928 solubilization Effects 0.000 abstract 1
- 238000005063 solubilization Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 229940076788 pyruvate Drugs 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 150000007524 organic acids Chemical class 0.000 description 9
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 229940093915 gynecological organic acid Drugs 0.000 description 7
- 229910017053 inorganic salt Inorganic materials 0.000 description 7
- 235000005985 organic acids Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000000174 gluconic acid Substances 0.000 description 4
- 235000012208 gluconic acid Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 235000011054 acetic acid Nutrition 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000985513 Penicillium oxalicum Species 0.000 description 2
- 102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 229940116315 oxalic acid Drugs 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 108020003519 protein disulfide isomerase Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- DPZHKLJPVMYFCU-UHFFFAOYSA-N 2-(5-bromopyridin-2-yl)acetonitrile Chemical compound BrC1=CC=C(CC#N)N=C1 DPZHKLJPVMYFCU-UHFFFAOYSA-N 0.000 description 1
- 101150033839 4 gene Proteins 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000956177 Aspergillus kawachii IFO 4308 Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000013460 Malate Dehydrogenase Human genes 0.000 description 1
- 108010026217 Malate Dehydrogenase Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- RWYFURDDADFSHT-RBBHPAOJSA-N diane Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C1=C(Cl)C2=CC(=O)[C@@H]3CC3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RWYFURDDADFSHT-RBBHPAOJSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- WUJISAYEUPRJOG-UHFFFAOYSA-N molybdenum vanadium Chemical compound [V].[Mo] WUJISAYEUPRJOG-UHFFFAOYSA-N 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940095574 propionic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012106 screening analysis Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/38—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
技术领域technical field
本发明属于生物技术领域,具体涉及一种促进丙酮酸分泌的基因及其应用。The invention belongs to the field of biotechnology, and in particular relates to a gene for promoting pyruvate secretion and application thereof.
背景技术Background technique
微生物在生长过程中能够分泌各种有机酸,比较常见的有机酸有琥珀酸、柠檬酸、α-酮戊二酸、苹果酸、丙酮酸、乳酸、乙酸、甲酸、丙酸、富马酸和草酸。这些有机酸具有多种作用,在农业上,能够溶解土壤无机磷提高土壤磷素的利用率,有机酸与土壤中铁、铝、钙等离子螯合,从而使难溶磷转化为有效磷,提高磷肥利用率。Microorganisms can secrete various organic acids during the growth process. The more common organic acids are succinic acid, citric acid, α-ketoglutaric acid, malic acid, pyruvic acid, lactic acid, acetic acid, formic acid, propionic acid, fumaric acid and oxalic acid. These organic acids have multiple functions. In agriculture, they can dissolve soil inorganic phosphorus and improve the utilization rate of soil phosphorus. Organic acids can chelate with iron, aluminum, calcium and other ions in the soil, so that insoluble phosphorus can be converted into available phosphorus, and phosphorus fertilizer can be improved. utilization rate.
丙酮酸分子式CH3COCOOH,可通过乙酰CoA和三羧酸循环实现体内糖、脂肪和氨基酸间的互相转化,在三大营养物质的代谢联系中起着重要的枢纽作用,是参与整个生物体基本代谢的中间产物之一。丙酮酸用途和广泛,可用于生产色氨酸、苯丙氨酸和维生素B的主要原料,是生物合成L-多巴的原料,也是乙烯聚合物的起始剂,是杀菌剂噻菌灵的中间体,也是一种食品用香料;丙酮酸及它生成的盐,在医药领域应用很广,用于生产镇静剂、抗氧剂、抗病毒剂、合成治疗高血压的药物等等。The molecular formula of pyruvate is CH 3 COCOOH, which can realize the interconversion of sugar, fat and amino acid in the body through the acetyl CoA and tricarboxylic acid cycle. It plays an important pivotal role in the metabolic connection of the three major nutrients and is the basic One of the intermediate products of metabolism. Pyruvate has a wide range of uses and can be used as the main raw material for the production of tryptophan, phenylalanine and vitamin B. It is the raw material for the biosynthesis of L-dopa and the initiator of ethylene polymers. The intermediate is also a spice for food; pyruvic acid and its salts are widely used in the field of medicine, for the production of sedatives, antioxidants, antiviral agents, synthetic drugs for the treatment of high blood pressure, etc.
微生物的溶磷机理大致分为5种:有机酸、氢质子(NH4-N供应)、磷酸酶(蛋白质)、螯合作用和氧化还原,其中产生有机酸是一种主要的溶磷方式,有机酸能与铁、铝、钙等离子螯合,从而使难溶磷转化为有效磷(唐超西,龚明波,2012,中国农业科学,45(18):3792-3800.)。The phosphorus-dissolving mechanism of microorganisms can be roughly divided into five types: organic acid, hydrogen proton (NH 4 -N supply), phosphatase (protein), chelation, and redox. Among them, the production of organic acid is the main phosphorus-dissolving method. Organic acids can chelate with iron, aluminum, calcium and other ions, thereby converting insoluble phosphorus into available phosphorus (Tang Chaoxi, Gong Mingbo, 2012, Chinese Agricultural Sciences, 45(18):3792-3800.).
关于溶磷相关基因研究以细菌为主,其主要机制是将葡萄糖直接氧化产生葡萄糖酸(GA),其中葡萄糖酸的合成是由葡萄糖脱氢酶(GDH)和协同因子吡咯喹啉奎宁(PQQ)完成(GoldsteinAH,1999,FEMSMicrobiologyEcology,30(4):295-300.)。目前关于真菌溶磷相关基因的克隆也有报道,主要是以黑曲霉和草酸青霉为主,但其数量非常少,主要机制也不是很明确,也有报道从草酸青霉中克隆到的基因编码合成苹果酸脱氢酶在大肠杆菌中表达,分泌苹果酸、乳酸、醋酸、柠檬酸、草酸等有机酸从而使难溶磷溶解(GongMB,2014,CanadianJournalofMicrobiology,60:1-5)。The research on phosphorus-dissolving related genes is mainly based on bacteria, and its main mechanism is to directly oxidize glucose to produce gluconic acid (GA). ) done (Goldstein AH, 1999, FEMS Microbiology Ecology, 30(4):295-300.). At present, there are also reports on the cloning of fungal phosphorus-soluble related genes, mainly Aspergillus niger and Penicillium oxalicum, but their number is very small, and the main mechanism is not very clear. There are also reports of gene coding synthesis cloned from Penicillium oxalicum Malate dehydrogenase is expressed in Escherichia coli and secretes malic acid, lactic acid, acetic acid, citric acid, oxalic acid and other organic acids to dissolve insoluble phosphorus (GongMB, 2014, Canadian Journal of Microbiology, 60:1-5).
目前,在ncbi数据库中发布了真菌AspergillusnigerCBS513.88(XM_001398218.2)的全基因组序列,与本发明序列同源性都为99%,该基因编码的蛋白与AspergillusnigerCBS513.88编码的蛋白disulfideisomerase(XP_001399725.1)的蛋白同源性为100%以及AspergilluskawachiiIFO4308编码的蛋白disulfideisomerase(GAA82152.1)的蛋白同源性为99%,但未报到其具有产生丙酮酸的功能。其它报道的都为假定蛋白,没有进行功能分析。At present, the complete genome sequence of the fungus Aspergillus niger CBS513.88 (XM_001398218.2) has been released in the ncbi database, and its homology with the sequence of the present invention is 99%. The protein encoded by this gene is the protein disulfideisomerase (XM_001399725. The protein homology of 1) is 100% and that of the protein disulfideisomerase (GAA82152.1) encoded by Aspergillus kawachii IFO4308 is 99%, but it has not been reported that it has the function of producing pyruvate. The other reports are hypothetical proteins without functional analysis.
发明内容Contents of the invention
针对本领域存在的不足之处,本发明的目的是提出一种促进分泌丙酮酸的基因psaC。Aiming at the deficiencies in the art, the purpose of the present invention is to provide a gene psaC that promotes the secretion of pyruvate.
本发明的另一目的是提出所述基因psaC的提取方法。Another object of the present invention is to propose a method for extracting the gene psaC.
本发明的第三个目的是提出所述基因psaC的应用。The third object of the present invention is to propose the application of said gene psaC.
实现本发明上述目的技术方案为:Realize above-mentioned object technical scheme of the present invention is:
一种基因psaC,所述基因psaC的核苷酸序列如SEQIDNo.1所示。A gene psaC, the nucleotide sequence of the gene psaC is shown in SEQ ID No.1.
一种所述的基因psaC编码的蛋白,所述蛋白的氨基酸序列如SEQIDNo.2所示。A protein encoded by the gene psaC, the amino acid sequence of the protein is shown in SEQ ID No.2.
本发明所述基因psaC的提取方法,包括步骤:The extraction method of the gene psaC of the present invention comprises the steps of:
1)在难溶磷无机盐培养基上培养黑曲霉菌H1(AspergillusnigerH1),从培养的黑曲霉菌H1基因组中提取总RNA,再从总RNA中纯化出mRNA,用引物5'-(GA)10ACTAGTCTCGAG(T)18V-3’(V:AorCorG扩增,合成cDNA第一链;1) Cultivate Aspergillus niger H1 (Aspergillus nigerH1) on the insoluble phosphorus inorganic salt medium, extract total RNA from the cultured Aspergillus niger H1 genome, then purify mRNA from the total RNA, and use primer 5'-(GA) 10 ACTAGTCTCGAG (T) 18V-3' (V: AorCorG amplification, synthetic cDNA first strand;
2)cDNA第一链以5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3为引物,通过LD-PCR合成双链cDNA,2) The first strand of cDNA uses 5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3 as a primer to synthesize double-stranded cDNA by LD-PCR,
3)将cDNA序列连接到pBluescriptSKII(+)上,连接产物电转化到大肠杆菌上,通过难溶磷培养基筛选具有溶磷透明圈的转化子;3) Ligate the cDNA sequence to pBluescriptSKII(+), electrotransform the ligation product into Escherichia coli, and screen the transformant with a phosphorus-dissolving transparent circle through the insoluble phosphorus medium;
4)筛选出的转化子进行转接培养,筛选克隆子进行测序分析,得到全长为1007bp的cDNA序列,利用DNAMAN分析其基因开放阅读框为208个氨基酸。4) The selected transformants were transferred and cultured, and the clones were screened for sequencing analysis to obtain a cDNA sequence with a full length of 1007 bp. The open reading frame of the gene was analyzed by DNAMAN to be 208 amino acids.
其中,步骤1)可用RNAisoplus试剂盒提取总RNA,用OligotexmRNAMiniKit试剂盒从总RNA中纯化mRNA。Wherein, step 1) can use RNAisoplus kit to extract total RNA, and use OligotexmRNAMiniKit kit to purify mRNA from total RNA.
PCR反应条件可以为:95℃预变性1min;95℃变性15s;65℃退火30s,68℃延伸6min,30cycles4℃forever。The PCR reaction conditions can be: pre-denaturation at 95°C for 1 min; denaturation at 95°C for 15 s; annealing at 65°C for 30 s, extension at 68°C for 6 min, and 30 cycles at 4°C forever.
其中,步骤3)所述电转化的条件为:每50μL大肠杆菌感受态细胞施加电量25μF,电击的电压为1.5KV。Wherein, the conditions for electrotransformation in step 3) are as follows: an electric charge of 25 μF is applied per 50 μL of Escherichia coli competent cells, and the electric shock voltage is 1.5 KV.
本发明还提出含有本发明所述基因的载体。The present invention also proposes a vector containing the gene of the present invention.
其中,所述载体可以为表达载体pBluescriptSKII(+)。Wherein, the vector may be the expression vector pBluescriptSKII(+).
含有本发明所述基因的工程菌。An engineering bacterium containing the gene of the present invention.
其中,所述工程菌为大肠杆菌。所述大肠杆菌可以为E.coliHST08。Wherein, the engineering bacterium is Escherichia coli. The Escherichia coli can be E.coliHST08.
本发明还提出所述基因的应用,即,基因psaC在生产丙酮酸中的应用。The present invention also proposes the use of said gene, ie the use of the gene psaC in the production of pyruvate.
以及,基因psaC在溶解无机难溶磷中的应用。And, the application of gene psaC in dissolving inorganic insoluble phosphorus.
本发明从黑曲霉H1中克隆溶磷基因,其编码的蛋白导入大肠杆菌中,在难溶磷无机盐培养基中培养36h时,促进大肠杆菌分泌丙酮酸,含量达到1706μg/mL,溶液的pH值从6.45降到3.34,释放的可溶磷含量为0.18mg/mL。The present invention clones the phosphorus-dissolving gene from Aspergillus niger H1, and the encoded protein is introduced into Escherichia coli, and when cultured in the insoluble phosphorus inorganic salt medium for 36 hours, the secretion of pyruvate by Escherichia coli is promoted, and the content reaches 1706 μg/mL, and the pH of the solution is The value dropped from 6.45 to 3.34, and the released soluble phosphorus content was 0.18 mg/mL.
本发明的有益效果在于:The beneficial effects of the present invention are:
1、本发明首先提供了溶磷基因psaC的核苷酸序列;1. The present invention firstly provides the nucleotide sequence of the phosphorus-dissolving gene psaC;
2、本发明通过异源表达克隆得到的溶磷基因,利用大肠杆菌可高效产生丙酮酸;2. The phosphorus-dissolving gene obtained by heterologous expression and cloning in the present invention can efficiently produce pyruvate by using Escherichia coli;
3、本发明通过异源表达克隆到的溶磷基因具有将难溶磷转化为有效磷的效果。3. The phosphorus-dissolving gene cloned through heterologous expression in the present invention has the effect of converting insoluble phosphorus into available phosphorus.
附图说明Description of drawings
图1为实施例1黑曲霉菌H1在难溶磷无机盐培养基上培养3d的形态。Fig. 1 is the morphology of embodiment 1 Aspergillus niger H1 cultured on the insoluble phosphorus inorganic salt medium for 3 days.
图2为实施例1黑曲霉菌H1的总RNA图。Figure 2 is a graph of total RNA of Aspergillus niger H1 in Example 1.
图3为实施例2中携带溶磷基因的克隆子。Figure 3 is the clone carrying the phosphate-dissolving gene in Example 2.
图4为工程菌培养不同溶液pH值的变化。Fig. 4 is the change of pH value of different solutions for engineering bacteria culture.
图5为工程菌培养不同溶液可溶磷含量的变化。Figure 5 shows the change of soluble phosphorus content in different solutions of engineered bacteria culture.
图6为实施例5大肠杆菌产丙酮酸的液相色谱图。6 is a liquid chromatogram of pyruvate produced by Escherichia coli in Example 5.
图7为5200mg/L的丙酮酸标准样品液相色谱图。Fig. 7 is the liquid phase chromatogram of the pyruvate standard sample of 5200mg/L.
具体实施方式detailed description
下面结合附图和实施例,对本发明的具体实施方式作进一步详细描述。本领域技术人员应当知晓,本发明的范围不仅限于特定的实施方案,在不脱离本发明的精神下可以进行各种修饰和改变。The specific implementation manners of the present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood by those skilled in the art that the scope of the present invention is not limited to the specific embodiments, and various modifications and changes can be made without departing from the spirit of the present invention.
实施例中,大肠杆菌菌种购自大肠杆菌菌种购自生工生物工程(上海)股份有限公司。In the examples, Escherichia coli strains were purchased from Sangon Bioengineering (Shanghai) Co., Ltd.
如未特别说明,具体实施方式中所采用的手段均为本领域常规的技术手段。Unless otherwise specified, the means adopted in the specific embodiment are conventional technical means in the field.
实施例1黑曲霉菌的cDNA全长文库构建The cDNA full-length library construction of embodiment 1 Aspergillus niger
实验所用菌株黑曲霉H1为中国农业科学院农业资源与农业区划研究所农业菌种保藏中心从土壤样品中筛选,在难溶磷无机盐培养基上培养3d,取0.2g左右新鲜菌丝(如图1),液氮研磨,利用RNAisoplus试剂盒提取总RNA,用OligotexmRNAMiniKit试剂盒从总RNA中纯化出mRNA。每个离心管加入2μL纯化的mRNA,1μL浓度为12μM的3’SMARTCDSPrimerIIA(5'-(GA)10ACTAGTCTCGAG(T)18V-3’(V:AorCorG)),最后用RNaseFreeH2O补足至终体积为4.5μL,使溶液充分混匀后离心,72℃水浴3min,立即转到42℃水浴2min,立即向每个离心管中加入5.5μL混合液(表1),充分混匀后离心,置于42℃水浴90min,立即放置冰上,cDNA第一链合成,产物立即进行LD-PCR或-20℃保存备用。The strain Aspergillus niger H1 used in the experiment was screened from soil samples by the Agricultural Strain Preservation Center of the Institute of Agricultural Resources and Agricultural Regional Planning, Chinese Academy of Agricultural Sciences. It was cultivated on the insoluble phosphorus inorganic salt medium for 3 days, and about 0.2 g of fresh mycelium was taken (as shown in the figure 1) Grinding with liquid nitrogen, using the RNAisoplus kit to extract total RNA, and using the OligotexmRNAMiniKit kit to purify mRNA from the total RNA. Add 2 μL of purified mRNA to each centrifuge tube, 1 μL of 12 μM 3'SMARTCDSPrimerIIA (5'-(GA) 10 ACTAGTCTCGAG(T)18V-3'(V:AorCorG)), and finally make up to the final volume with RNaseFreeH 2 O 4.5 μL, make the solution fully mixed and centrifuge, 72 ° C water bath for 3 min, immediately transfer to 42 ° C water bath for 2 min, immediately add 5.5 μ L of the mixed solution (Table 1) to each centrifuge tube, mix well and centrifuge, place in Water bath at 42°C for 90 minutes, immediately placed on ice, the first strand of cDNA was synthesized, and the product was immediately subjected to LD-PCR or stored at -20°C for later use.
表1第一链合成混合液Table 1 First strand synthesis mixture
以2μL第一链cDNA产物为模板,SMARTerIIA(5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3)为引物,通过LD-PCR合成双链cDNA,反应体系见表2,PCR反应条件设定:95℃预变性1min;95℃变性15s;65℃退火30s,68℃延伸6min,30cycles4℃forever。将PCR扩增产物取3.0μL用1.0%琼脂糖凝胶中电泳检测。Using 2 μL of the first-strand cDNA product as a template and SMARTerIIA (5'-AAGCTTAAGGGTATCAACGCAGAGTAC-3) as a primer, double-stranded cDNA was synthesized by LD-PCR. Denaturation at ℃ for 15s; annealing at 65℃ for 30s, extension at 68℃ for 6min, 30cycles at 4℃forever. 3.0 μL of the PCR amplification product was detected by electrophoresis in 1.0% agarose gel.
表2第二链合成反应体系Table 2 Second chain synthesis reaction system
利用CHROMASPIN+TE-1000纯化cDNA,去除小于500bp的片段,沉淀回收cDNA片段。用T4DNA聚合酶补平cDNA的末端后,在其两端连接EcoRI/XhoI定向接头,并用EcoRI/XhoI对接头进行酶切,得到5’端为EcoRI、3’端为HindIII酶切位点的双黏性末端cDNA。纯化后的cDNA片段通过T4DNA连接酶连接到经过EcoRI/XhoI双酶切的pBluescriptSKII(+)载体上,将连接产物电转化到宿主菌E.coliHST08,具体操作如下:Use CHROMASPIN+TE-1000 to purify cDNA, remove fragments smaller than 500bp, and precipitate and recover cDNA fragments. After the ends of the cDNA were blunted with T4 DNA polymerase, EcoRI/XhoI directional adapters were connected at both ends, and the adapters were digested with EcoRI/XhoI to obtain a double DNA with EcoRI at the 5' end and HindIII restriction site at the 3' end. Sticky-ended cDNA. The purified cDNA fragment was connected to the EcoRI/XhoI double digested pBluescriptSKII(+) vector by T4 DNA ligase, and the ligated product was electrotransformed into the host strain E.coliHST08, the specific operation was as follows:
1)超低温冰箱中取出E.coliHST08感受态细胞(50μL)置于冰中融化。1) Take out E.coliHST08 competent cells (50 μL) from the ultra-low temperature refrigerator and put them in ice to thaw.
2)E.coliHST08感受态细胞完全融化后立即加入2μL重组质粒,并均匀。2) After E.coliHST08 competent cells are completely thawed, add 2 μL of recombinant plasmid immediately and mix well.
3)将混匀液立即加到预冷的0.1cm冲击槽内。3) Immediately add the mixed solution into the pre-cooled 0.1cm impact tank.
4)电转化条件为1.5KV,200Ω,25μF,电转化结束后迅速将离心管置于冰中冷却,并加入1mLLB培养基。4) The electroporation conditions were 1.5KV, 200Ω, 25μF. After the electroporation was completed, the centrifuge tube was quickly placed in ice to cool, and 1 mL of LB medium was added.
5)将加入LB的离心管于37℃200r/min振荡培养1h。5) Shake the centrifuge tube added with LB at 37° C. at 200 r/min for 1 hour.
取10μL转化液涂布LB培养基上过夜培养,随机挑取转化后的克隆子,在LB培养液中培养过夜,提取质粒,将质粒用EcoRI和XhoI酶切质粒,检测连接片段的大小,结果显示插入大小为600bp~3kb(图2)。将转化后的宿主菌接种在2mLLB液体培养基中37℃温浴2h,得到初级cDNA文库,4℃保存备用。Take 10 μL of transformation solution and spread it on LB medium for overnight culture, pick the transformed clones at random, culture them overnight in LB medium, extract the plasmid, digest the plasmid with EcoRI and XhoI, and detect the size of the connected fragment. It was shown that the insert size was 600bp~3kb (Fig. 2). The transformed host bacteria were inoculated in 2 mL of LB liquid medium and incubated at 37°C for 2 hours to obtain a primary cDNA library, which was stored at 4°C for future use.
实施例2基因的筛选及生物信息学分析Screening and bioinformatics analysis of embodiment 2 genes
将含有文库细菌的培养液稀释涂布到含有氨苄青霉素(100μg/mL)难溶磷培养基上,37℃培养3-4d,观察是否有溶磷透明圈产生,以大肠杆菌E.coliHST08为受体菌,将产生透明圈的转化子转接培养,如图3所示,一共有169个克隆子在难溶磷培养基上出现透明圈,其中该克隆子的效果相对较好,将该克隆子提质粒测序得到DNA的序列,该cDNA序列全长1007bp,在NCBI上通过Blast进行比对分析,并利用DNAMAN6.0进行开放阅读框分析,该基因开放阅读框为208个氨基酸,标记为基因psaC,并将翻译蛋白在PDB数据库上比对分析。Dilute the culture solution containing the bacteria in the library onto the insoluble phosphorus medium containing ampicillin (100 μg/mL), culture at 37°C for 3-4 days, observe whether there is a phosphorus-dissolving transparent circle, and use Escherichia coli E.coliHST08 as the recipient As shown in Figure 3, a total of 169 clones appeared transparent circles on the insoluble phosphorus medium, and the effect of this clone was relatively good. The DNA sequence was obtained by sequencing the extracted plasmid. The full length of the cDNA sequence was 1007bp. It was compared and analyzed by Blast on NCBI, and the open reading frame was analyzed by DNAMAN6.0. The open reading frame of the gene is 208 amino acids, marked as gene psaC, and compared the translated proteins on the PDB database.
实施例3基因psaC对难溶磷无机盐培养液pH的影响Example 3 Effect of Gene psaC on the pH of Insoluble Phosphorous Inorganic Salt Culture Solution
将上述筛选出的克隆子接种到50mL带抗性(氨苄100ppm)的难溶磷无机盐培养液的150mL三角瓶中,培养基配方为:葡萄糖10g,(NH4)2SO40.5g,NaCl0.3g,KCl0.3g,MgSO4·7H2O0.3g,FeSO4·7H2O0.03g,MnSO4·4H2O0.03g,Ca3(PO4)210.0g,蒸馏水1000mL,pH值为6.45。The clones screened above were inoculated into a 150mL Erlenmeyer flask of 50mL of insoluble phosphorus inorganic salt culture solution with resistance (100ppm ampicillin). The medium formula was: glucose 10g, (NH 4 ) 2 SO 4 0.5g, NaCl0 .3g, KCl 0.3g, MgSO 4 7H 2 O 0.3g, FeSO 4 7H 2 O 0.03g, MnSO 4 4H 2 O 0.03g, Ca 3 (PO 4 ) 2 10.0g, distilled water 1000mL, pH value 6.45.
以大肠杆菌E.coliHST08为受体菌,接种含有基因的转化子和不含目的基因(只带有pBluescriptSKII(+)质粒)的大肠杆菌各1mL,37℃,200r/min培养,设置三个重复,在2h、4h、8h、12h、16h、20h、24h和36h测定溶液的pH值,在2h时,pH值开始明显下降,为6.0,随着时间的延长,接种转化子的溶液pH值迅速降低,在20h时,溶液pH值趋于稳定,在36h时,降到最低值达到3.34(图4),而不携带基因的大肠杆菌溶液pH最终降到5.6左右时不再变化。Using Escherichia coli E.coliHST08 as the recipient bacterium, inoculate 1 mL each of the transformants containing the gene and E. coli without the target gene (only with the pBluescriptSKII(+) plasmid), culture at 37°C, 200r/min, and set up three replicates , measure the pH value of the solution at 2h, 4h, 8h, 12h, 16h, 20h, 24h and 36h. At 2h, the pH value begins to drop significantly, which is 6.0. As time goes on, the pH value of the solution for inoculating transformants rapidly Reduced, at 20h, the solution pH tended to be stable, and at 36h, it dropped to the lowest value and reached 3.34 (Figure 4), and the pH of the solution of Escherichia coli that did not carry the gene finally dropped to about 5.6 and no longer changed.
实施例4基因psaC对难溶磷无机盐培养液难溶磷的溶解Example 4 Gene psaC dissolves insoluble phosphorus in insoluble phosphorus inorganic salt culture medium
实验操作同实验3,在4、8、12、16、24、36h时,将溶液离心取上清,105~110℃干燥后的磷酸二氢钾作为标样,用钒钼黄比色法测定可溶磷含量。溶液可溶磷的含量变化与溶液pH值成负相关,溶液pH值越低,释放的可溶磷含量越高,在36h溶液中可溶磷含量升到最高,达到0.18mg/mL(图5),不携带该基因的大肠杆菌培养液可溶磷含量没有变化。The experimental operation is the same as that of Experiment 3. At 4, 8, 12, 16, 24, and 36 hours, the solution is centrifuged to take the supernatant, and the potassium dihydrogen phosphate dried at 105-110°C is used as a standard sample, and is determined by the vanadium molybdenum yellow colorimetric method Soluble phosphorus content. The content change of soluble phosphorus in the solution is negatively correlated with the pH value of the solution. The lower the pH value of the solution, the higher the released soluble phosphorus content. The content of soluble phosphorus in the 36h solution rose to the highest level, reaching 0.18 mg/mL (Fig. 5 ), the soluble phosphorus content of the Escherichia coli culture fluid that did not carry the gene did not change.
实施例5基因psaC对大肠杆菌E.coliHST08产酸的影响Example 5 Effect of Gene psaC on Escherichia coli E.coliHST08 Acid Production
实验设计如同实施例3,在36h取出溶液上清,20000rpm离心,过滤后通过美国戴安公司ICS-3000液相色谱仪分析溶液中有机酸的种类和含量。采用的安捷伦的1100液相色谱,色谱柱为C18柱5μm(4×250mm),进柱体积10μL,流动相:甲醇,0.01mol/LKH2PO4缓冲液(pH2.80),淋洗液梯度洗脱程序为0~5min,100%磷酸缓冲液(pH2.80),5~15min,95%的磷酸缓冲液(pH2.80)和5%的甲醇,15~25min,55%的磷酸缓冲液(pH2.80)和45%的甲醇,25~30min,95%的磷酸缓冲液(pH2.80)和5%的甲醇,检测波长215nm,流速0.7ml/min,柱温25℃。培养36h后,不含psaC的E.coliHST08只产生少量乙酸,含量为18.5μg/mL,而含psaC的E.coliHST08分泌大量丙酮酸,液相色谱图显示,在4.874分钟时峰面积为11577.4,对应丙酮酸含量达到为1706μg/mL(图4,图5)。The experimental design was the same as in Example 3. The supernatant of the solution was taken out at 36 hours, centrifuged at 20,000 rpm, filtered and analyzed for the type and content of organic acids in the solution by an ICS-3000 liquid chromatograph from Diane Corporation. The Agilent 1100 liquid chromatography used, the chromatographic column is a C18 column 5 μm (4×250mm), the column volume is 10 μL, the mobile phase: methanol, 0.01mol/L KH 2 PO 4 buffer (pH 2.80), eluent gradient The elution program is 0~5min, 100% phosphate buffer (pH2.80), 5~15min, 95% phosphate buffer (pH2.80) and 5% methanol, 15~25min, 55% phosphate buffer (pH2.80) and 45% methanol, 25-30min, 95% phosphate buffer (pH2.80) and 5% methanol, detection wavelength 215nm, flow rate 0.7ml/min, column temperature 25°C. After culturing for 36 hours, E.coliHST08 without psaC produced only a small amount of acetic acid, with a content of 18.5 μg/mL, while E.coliHST08 containing psaC secreted a large amount of pyruvate. The liquid chromatography showed that the peak area was 11577.4 at 4.874 minutes, The corresponding content of pyruvate reached 1706 μg/mL (Fig. 4, Fig. 5).
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610096612.4A CN105624174B (en) | 2015-12-22 | 2016-02-22 | A kind of gene that promotes pyruvate secretion, its extraction method and application |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2015109701410 | 2015-12-22 | ||
CN201510970141 | 2015-12-22 | ||
CN201610096612.4A CN105624174B (en) | 2015-12-22 | 2016-02-22 | A kind of gene that promotes pyruvate secretion, its extraction method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105624174A true CN105624174A (en) | 2016-06-01 |
CN105624174B CN105624174B (en) | 2019-04-19 |
Family
ID=56039518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610096612.4A Expired - Fee Related CN105624174B (en) | 2015-12-22 | 2016-02-22 | A kind of gene that promotes pyruvate secretion, its extraction method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105624174B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409436A (en) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | Phosphate solubilizing gene for promoting organic acid secretion |
CN103409437A (en) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | Phosphate solubilizing gene for promoting acetic acid secretion |
-
2016
- 2016-02-22 CN CN201610096612.4A patent/CN105624174B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103409436A (en) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | Phosphate solubilizing gene for promoting organic acid secretion |
CN103409437A (en) * | 2013-08-20 | 2013-11-27 | 中国农业科学院农业资源与农业区划研究所 | Phosphate solubilizing gene for promoting acetic acid secretion |
Non-Patent Citations (1)
Title |
---|
NCBI REFERENCE SEQUENCE:XP_001399725: "XP_001399725", 《NCBI》 * |
Also Published As
Publication number | Publication date |
---|---|
CN105624174B (en) | 2019-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104611396B (en) | A method of producing glutathione | |
CN103614386B (en) | Caspian halostachys metallothionein gene and recombinant protein thereof and application | |
CN102220299B (en) | Feruloyl esterase A mutant and purpose thereof | |
CN102260692A (en) | Phytoene dehydrogenase gene and application thereof | |
CN111979168A (en) | A kind of genetic engineering bacteria and production method for improving lactoyl-N-trisaccharide II yield | |
CN111235169A (en) | A kind of GTP cyclohydrolase I gene folE and its application | |
CN107723252A (en) | Recombinant Yarrowia lipolytica producing valencia citrene and nokadone and its construction method | |
CN107338258A (en) | The method for producing the engineering bacteria structure and its production beta Alanine of beta Alanine | |
CN106191084A (en) | The clone of a kind of α L rhamnosidase gene, express and apply | |
CN114058560B (en) | Process for the production of glycine | |
CN105462949A (en) | Glutamic acid decarboxylase mutant and preparation method thereof and application | |
CN105238797B (en) | Mutant gene of gshF gene of streptococcus agalactiae and application thereof | |
CN104093836A (en) | Hydrocarbon Synthase Gene and Its Utilization | |
CN106011184A (en) | Noncellular synthetic biology based preparation method of 2-phenylethanol and application | |
CN104531637A (en) | Beta-glucosaccharase, beta-glucosaccharase mutant and application | |
CN110283797A (en) | A kind of tyrosinase and its gene, engineering bacteria and preparation method | |
CN105002192B (en) | A kind of malic enzyme gene RKME1 and its recombinant expression carrier | |
CN102010869A (en) | Gene of wintersweet late embryogenesis abundant protein (LEA) and low-temperature resistant application thereof | |
CN101492689A (en) | Corn C4 phosphoric acid enol pyruvic acid carboxylase gene and uses in producing wheat | |
CN108424937B (en) | A kind of method for synthesizing Danshensu by enzymatic method | |
CN105602880A (en) | Corynebacterium glutamicum and method for overproduction of phosphatidylserine by means of corynebacterium glutamicum | |
CN105349557B (en) | A kind of malic enzyme gene RKME2 and its recombinant expression carrier | |
CN105950596A (en) | Difunctional acid urease gene and expression and application thereof | |
CN105624174A (en) | Gene for promoting pyruvic acid secretion and extraction method and application thereof | |
CN103409437B (en) | Phosphate solubilizing gene for promoting acetic acid secretion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190419 Termination date: 20200222 |